ImmunoCellular Therapeutics Analysis
| IMUCDelisted Stock | USD 0.47 0.00 0.00% |
ImmunoCellular Therapeutics is overvalued with Real Value of 0.45 and Hype Value of 0.47. The main objective of ImmunoCellular Therapeutics pink sheet analysis is to determine its intrinsic value, which is an estimate of what ImmunoCellular Therapeutics is worth, separate from its market price. There are two main types of ImmunoCellular Therapeutics' stock analysis: fundamental analysis and technical analysis.
The ImmunoCellular Therapeutics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ImmunoCellular Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
ImmunoCellular |
ImmunoCellular Pink Sheet Analysis Notes
About 95.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.35. Some equities with similar Price to Book (P/B) outperform the market in the long run. ImmunoCellular Therapeutics recorded earning per share (EPS) of 28.91. The entity last dividend was issued on the 16th of September 2020. The firm had 1:10 split on the 16th of September 2020. Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New Jersey. Immunocellular Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.The quote for ImmunoCellular Therapeutics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about ImmunoCellular Therapeutics call BS MS at 201 351 0605 or check out https://www.eompharma.com.ImmunoCellular Therapeutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ImmunoCellular Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ImmunoCellular Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| ImmunoCellular Therapeutics is not yet fully synchronised with the market data | |
| ImmunoCellular Therapeutics has some characteristics of a very speculative penny stock | |
| ImmunoCellular Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (5.15 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ImmunoCellular Therapeutics currently holds about 933.15 K in cash with (2.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 95.0% of the company shares are held by company insiders |
ImmunoCellular Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.21 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ImmunoCellular Therapeutics's market, we take the total number of its shares issued and multiply it by ImmunoCellular Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.ImmunoCellular Therapeutics Outstanding Bonds
ImmunoCellular Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ImmunoCellular Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ImmunoCellular bonds can be classified according to their maturity, which is the date when ImmunoCellular Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| US45258LAA52 Corp BondUS45258LAA52 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
ImmunoCellular Therapeutics Predictive Daily Indicators
ImmunoCellular Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ImmunoCellular Therapeutics pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About ImmunoCellular Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how ImmunoCellular Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ImmunoCellular shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as ImmunoCellular Therapeutics. By using and applying ImmunoCellular Pink Sheet analysis, traders can create a robust methodology for identifying ImmunoCellular entry and exit points for their positions.
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Immunocellular Therapeutics, Ltd. was founded in 2020 and is headquartered in Montvale, New Jersey. Immunocellular Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding ImmunoCellular Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in ImmunoCellular Pink Sheet
If you are still planning to invest in ImmunoCellular Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ImmunoCellular Therapeutics' history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |